Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating
Maxim Group Keeps Their Hold Rating on Nuwellis (NUWE)
Roth MKM Maintains Nuwellis(NUWE.US) With Buy Rating, Maintains Target Price $17
Roth MKM Reiterates Buy on Nuwellis, Maintains $17 Price Target
Nuwellis Analyst Ratings
Roth MKM Initiates Nuwellis(NUWE.US) With Buy Rating, Announces Target Price $17
Nuwellis Analyst Ratings
Roth MKM Initiates Nuwellis at Buy With $17 Price Target
Maxim Group Keeps Their Buy Rating on Nuwellis (NUWE)
Nuwellis (NUWE) Gets a Buy From Maxim Group
Nuwellis Analyst Ratings
Nuwellis (NUWE) Gets a Buy From Maxim Group
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Nuwellis (NUWE)
Nuwellis (NUWE) Gets a Buy From Maxim Group
Maxim Group Reaffirms Their Buy Rating on Nuwellis (NUWE)
No Data
No Data